Details

Autor(en) / Beteiligte

• Sachs, Gary S
• Nierenberg, Andrew A
• Calabrese, Joseph R
• Marangell, Lauren B
• Wisniewski, Stephen R
• Gyulai, Laszlo
• Friedman, Edward S
• Bowden, Charles L
• Fossey, Mark D
• Ostacher, Michael J
• Ketter, Terence A
• Patel, Jayendra
• Hauser, Peter
• Rapport, Daniel
• Martinez, James M
• Allen, Michael H
• Miklowitz, David J
• Otto, Michael W
• Dennehy, Ellen B
• Thase, Michael E

Titel

Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

Ist Teil von

• The New England journal of medicine, 2007-04, Vol.356 (17), p.1711-1722

Ort / Verlag

Boston, MA: Massachusetts Medical Society

Erscheinungsjahr

2007

Quelle

MEDLINE

Beschreibungen/Notizen

• The risks and benefits of standard antidepressants for patients with bipolar disorder are not well understood. In this randomized, placebo-controlled trial of patients with bipolar disorder, all of whom received a mood stabilizer, adjunctive treatment with an antidepressant did not reduce the symptoms of bipolar depression or increase the risk of mania. In patients with bipolar disorder, all of whom received a mood stabilizer, adjunctive treatment with an antidepressant did not reduce the symptoms of bipolar depression or increase the risk of mania. Bipolar disorder, the sixth-leading cause of disability worldwide, 1 is a chronic and recurrent psychiatric illness with a lifetime prevalence of just under 4% 2 and annual costs that exceed those of diabetes or recurrent (unipolar) major depressive disorder. 3 Although abnormal mood elevation is the cardinal diagnostic feature that distinguishes bipolar disorder from recurrent major depressive disorder, depression that alternates with manic episodes (bipolar depression) is the leading cause of impairment and death among patients with bipolar disorders. 4 – 6 Two main limitations related to standard antidepressant medications hamper their use in the treatment of bipolar depression. First, though these agents have proved . . .